BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Arastehfar A, Carvalho A, Houbraken J, Lombardi L, Garcia-Rubio R, Jenks JD, Rivero-Menendez O, Aljohani R, Jacobsen ID, Berman J, Osherov N, Hedayati MT, Ilkit M, Armstrong-James D, Gabaldón T, Meletiadis J, Kostrzewa M, Pan W, Lass-Flörl C, Perlin DS, Hoenigl M. Aspergillus fumigatus and aspergillosis: From basics to clinics. Stud Mycol 2021;100:100115. [PMID: 34035866 DOI: 10.1016/j.simyco.2021.100115] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Fan Y, Korfanty GA, Xu J. Genetic Analyses of Amphotericin B Susceptibility in Aspergillus fumigatus. J Fungi (Basel) 2021;7:860. [PMID: 34682281 DOI: 10.3390/jof7100860] [Reference Citation Analysis]
2 Yaakoub H, Sanchez NS, Ongay-Larios L, Courdavault V, Calenda A, Bouchara JP, Coria R, Papon N. The high osmolarity glycerol (HOG) pathway in fungi. Crit Rev Microbiol 2021;:1-39. [PMID: 34893006 DOI: 10.1080/1040841X.2021.2011834] [Reference Citation Analysis]
3 Hoenigl M, Sprute R, Egger M, Arastehfar A, Cornely OA, Krause R, Lass-Flörl C, Prattes J, Spec A, Thompson GR 3rd, Wiederhold N, Jenks JD. The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin. Drugs 2021;81:1703-29. [PMID: 34626339 DOI: 10.1007/s40265-021-01611-0] [Reference Citation Analysis]
4 Ghobadi E, Saednia S, Emami S. Synthetic approaches and structural diversity of triazolylbutanols derived from voriconazole in the antifungal drug development. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114161] [Reference Citation Analysis]
5 Prattes J, Wauters J, Giacobbe DR, Salmanton-García J, Maertens J, Bourgeois M, Reynders M, Rutsaert L, Van Regenmortel N, Lormans P, Feys S, Reisinger AC, Cornely OA, Lahmer T, Valerio M, Delhaes L, Jabeen K, Steinmann J, Chamula M, Bassetti M, Hatzl S, Rautemaa-Richardson R, Koehler P, Lagrou K, Hoenigl M; ECMM-CAPA Study Group. Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology. Clin Microbiol Infect 2021:S1198-743X(21)00474-2. [PMID: 34454093 DOI: 10.1016/j.cmi.2021.08.014] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Sabino R, Veríssimo C. Novel Clinical and Laboratorial Challenges in Aspergillosis. Microorganisms 2022;10:259. [DOI: 10.3390/microorganisms10020259] [Reference Citation Analysis]
7 Palmieri F, Koutsokera A, Bernasconi E, Junier P, von Garnier C, Ubags N. Recent Advances in Fungal Infections: From Lung Ecology to Therapeutic Strategies With a Focus on Aspergillus spp. Front Med 2022;9:832510. [DOI: 10.3389/fmed.2022.832510] [Reference Citation Analysis]
8 Kumar M, Tiwari A, Asdaq SMB, Nair AB, Bhatt S, Shinu P, Al Mouslem AK, Jacob S, Alamri AS, Alsanie WF, Alhomrani M, Tiwari V, Devi S, Pathania A, Sreeharsha N. Itraconazole loaded nano-structured lipid carrier for topical ocular delivery: Optimization and evaluation. Saudi J Biol Sci 2022;29:1-10. [PMID: 35002390 DOI: 10.1016/j.sjbs.2021.11.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Gonçalves SM, Cunha C, Carvalho A. Understanding the genetic basis of immune responses to fungal infection. Expert Rev Anti Infect Ther 2022. [PMID: 35385368 DOI: 10.1080/14787210.2022.2063839] [Reference Citation Analysis]
10 Misslinger M, Petrik M, Pfister J, Hubmann I, Bendova K, Decristoforo C, Haas H. Desferrioxamine B-Mediated Pre-Clinical In Vivo Imaging of Infection by the Mold Fungus Aspergillus fumigatus. J Fungi (Basel) 2021;7:734. [PMID: 34575772 DOI: 10.3390/jof7090734] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Hatzl S, Reisinger AC, Posch F, Prattes J, Stradner M, Pilz S, Eller P, Schoerghuber M, Toller W, Gorkiewicz G, Metnitz P, Rief M, Prüller F, Rosenkranz AR, Valentin T, Krause R, Hoenigl M, Schilcher G. Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study. Crit Care 2021;25:335. [PMID: 34526087 DOI: 10.1186/s13054-021-03753-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Nargesi S, Jafarzadeh J, Najafzadeh MJ, Nouripour-Sisakht S, Haghani I, Abastabar M, Ilkit M, Hedayati MT. Molecular identification and antifungal susceptibility of clinically relevant and cryptic species of Aspergillus sections Flavi and Nigri. J Med Microbiol 2022;71. [PMID: 35451946 DOI: 10.1099/jmm.0.001480] [Reference Citation Analysis]
13 Sass G, Marsh JJ, Shrestha P, Sabino R, Stevens DA. Synergy Between Pseudomonas aeruginosa Filtrates And Voriconazole Against Aspergillus fumigatus Biofilm Is Less for Mucoid Isolates From Persons With Cystic Fibrosis. Front Cell Infect Microbiol 2022;12:817315. [DOI: 10.3389/fcimb.2022.817315] [Reference Citation Analysis]
14 Egger M, Bussini L, Hoenigl M, Bartoletti M. Prevalence of COVID-19-Associated Pulmonary Aspergillosis: Critical Review and Conclusions. JoF 2022;8:390. [DOI: 10.3390/jof8040390] [Reference Citation Analysis]
15 Doughty KJ, Sierotzki H, Semar M, Goertz A. Selection and Amplification of Fungicide Resistance in Aspergillus fumigatus in Relation to DMI Fungicide Use in Agronomic Settings: Hotspots versus Coldspots. Microorganisms 2021;9:2439. [PMID: 34946041 DOI: 10.3390/microorganisms9122439] [Reference Citation Analysis]
16 Badali H, Cañete-gibas C, Mccarthy D, Patterson H, Sanders C, David MP, Mele J, Fan H, Wiederhold NP, Hanson KE. Species Distribution and Antifungal Susceptibilities of Aspergillus Section Fumigati Isolates in Clinical Samples from the United States. J Clin Microbiol. [DOI: 10.1128/jcm.00280-22] [Reference Citation Analysis]
17 Egger M, Penziner S, Dichtl K, Gornicec M, Kriegl L, Krause R, Khong E, Mehta S, Vargas M, Gianella S, Porrachia M, Jenks JD, Venkataraman I, Hoenigl M. Performance of the Euroimmun Aspergillus Antigen ELISA for the Diagnosis of Invasive Pulmonary Aspergillosis in Bronchoalveolar Lavage Fluid. J Clin Microbiol 2022;:e0021522. [PMID: 35350844 DOI: 10.1128/jcm.00215-22] [Reference Citation Analysis]